ACIU Stock Analysis: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.79
0.04 (1.45%)
▲
5d:
-5.1%
30d:
-4.12%
90d:
-11.43%
HOLD
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 29, 2026
26d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACIU shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ACIU shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.07
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.53
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.79, which is considered slightly low relative to its 30-day fair value range of $2.72 to $3.05. The stock's valuation (Forward PE: 5.8) is in line with its historical norms (6.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.55, while resistance sits at $3.20.
Market Sentiment: ACIU has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.93 (+220.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.55, while resistance sits at $3.20.
Market Sentiment: ACIU has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.93 (+220.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$2.72 -
$3.05
Company Quality Score
47/100
(HOLD)
Options IV Signal
2th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 2th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 220.2% below Wall St target ($8.93)
- CAUTION: Recommendation downgraded due to -5.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.72 -
$3.05
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.33
(11.8%)
Support & Resistance Levels
Support Level
$2.55
Resistance Level
$3.20
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.76
Wall Street Target
$8.93
(+220.2%)
Revenue Growth (YoY)
-70.3%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
5.8 vs 6.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$2.75
(-1%)
2-Year Target
$2.71
(-3%)
3-Year Target
$2.67
(-4%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
$2.79
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.8 to 6.0
Stabilization Target:
$2.91
(+4.2%)
PE Expansion Potential:
+4.2%
Share & Embed Analysis
Last updated: April 02, 2026 6:06 AM ET
Data refreshes hourly during market hours. Next update: 7:06 AM
Data refreshes hourly during market hours. Next update: 7:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 51 HOLD |
